Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-07-26
1991-07-30
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Lymphokine
424 852, 424 856, 435 6951, 435 6952, 4351323, 514 2, 514 8, 514 12, 530351, 530809, A61K 4500, A61K 3702, C07K 1506, C12P 2106
Patent
active
RE0336530
ABSTRACT:
Muteins of biologically active proteins such as IFN-.beta. and IL-2 in which cysteine residues that are not essential to biological activity have been deleted or replaced with other amino acids to eliminate sites for intermolecular crosslinking or incorrect intramolecular disulfide bridge formation. These muteins are made via bacterial expression of mutant genes that encode the muteins that have been synthesized from the genes for the parent proteins by oligonucleotide-directed mutagenesis.
REFERENCES:
patent: 4401756 (1983-08-01), Gillis
patent: 4414150 (1983-11-01), Goeddel
patent: 4448879 (1984-05-01), Fabricius et al.
patent: 4490289 (1984-12-01), Stern
patent: 4564593 (1986-01-01), Tsukamoto et al.
patent: 4738927 (1988-04-01), Taniguchi et al.
patent: 4778879 (1988-10-01), Mertelsmann et al.
Liang et al., J. Biol. Chem., vol. 261, No. 1, pp. 334-337, (1986).
Stern et al., Proc. Natl. Acad. Sci., vol. 81, pp. 871-875, (1984).
Altman et al., Proc. Natl. Acad. Sci., vol. 81, pp. 2176-2180, (1984).
Shiroishi et al., Proc. Natl. Acad. Sci., vol. 81, pp. 7544-7548, (1984).
Taniguchi et al., Nature, vol. 285, pp. 547-549, (1980).
Lathe et al., Genetic Engineering, Academic Press, (1983), pp. 31-50.
Smith et al., Genetic Engineering, Principles and Methods, Plenum Press, (1981), 3:1-32.
Goeddel et al., Nucleic Acids Research, vol. 8, No. 18, pp. 4057-4074, (1980).
Taniguchi et al., PNAS, vol. 77, No. 9, pp. 5230-5233, (1980).
Allen et al., Nature, vol. 287, pp. 408-410, (1980).
Levy et al., PNAS, vol. 78, No. 10, pp. 6186-6190, (1981).
Knight et al., J. Interferon Res., vol. 2, No. 3, pp. 421-429, (1982).
Glossary of Genetics and Cytogenetics, 4th Ed., p. 381, Springer-Verlag, (1976).
Shepard et al., Nature, vol. 294, pp. 563-565, (1981).
Taniguchi et al., Gene, vol. 10, pp. 11-15, (1980).
Lin Leo S.
Lu Shi-da Y.
Mark David F.
Cetus Corporation
Halluin Albert P.
McGarrigle Philip L.
Moezie F. T.
Rozycki Andrew G.
LandOfFree
Human recombinant interleukin-2 muteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human recombinant interleukin-2 muteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human recombinant interleukin-2 muteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1535076